SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (1073)6/27/1997 1:36:00 AM
From: Howard Hoffman   of 1762
 
Bennet, it looks like this was a very short term buying opportunity. Anyone who had a buy in at 21 1/2 and had it filled Monday can be quite proud of themselves.
A lot of shares changed hands on Monday at bargain prices.

It looks like IDPH could even absorb the other shoe -- i.e. dropping CE9.1 altogether. Long-term, I have a lot of faith in Dr. Rastetter and his staff to come up with good products. Short term, I look forward to the approval of C2B8. The publicity potential will probably cause the stock to be overvalued. IMO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext